Infectoscab (Permethrin)

Permethrin disrupts the function of voltage‑gated sodium channels in the nervous system of parasites. By keeping these channels open, it causes prolonged nerve depolarization, leading to paralysis and death of the scabies mites or lice without significant absorption into the human bloodstream.

The specific dose and duration of treatment with Infectoscab are determined by the prescribing healthcare professional based on the patient’s age, weight, and severity of infestation. Always follow the prescriber’s instructions and the product label.

Safety data for permethrin use in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing Infectoscab to pregnant or nursing individuals. Consultation with a specialist is recommended.

To request Infectoscab, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Infectoscab (permethrin) is a synthetic pyrethroid, offering a favorable safety profile and high efficacy compared with older agents such as benzyl benzoate or sulfur ointments. It requires a single application in many cases, whereas some alternatives need multiple doses, but choice of therapy should be guided by clinical judgment and patient factors.

Store Infectoscab at room temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and extreme heat to maintain product stability and potency.

Infectoscab is applied topically to clean, dry skin covering the entire affected area. The medication is left on the skin for the duration specified by the prescriber, then washed off as directed. Avoid contact with eyes, mouth and open wounds unless instructed otherwise.

Serious adverse reactions are rare but may include allergic dermatitis, severe skin rash, swelling, or systemic toxicity such as dizziness or seizures, especially if applied over large body surface areas. Immediate medical attention is required if any of these symptoms develop.

Infectoscab should be avoided in individuals with known hypersensitivity to permethrin or any component of the formulation. It is also contraindicated on extensive broken skin, mucous membranes, or in patients where a prescriber determines the risks outweigh the benefits.